Qrono reformulates FDA approved medications with known safety and efficacy and creates new, long-acting medicines with improved clinical and economic benefits.
Qrono reformulates FDA approved drugs and creates long-acting injectable (LAI) medications with improved clinical and economic benefits. Our pipeline focuses on therapeutic areas where LAIs offer high therapeutic and economic value. We reduce risk since we are starting with FDA approved drugs that have known safety and efficacy. We use the accelerated FDA 505(b)(2) regulatory process that enables approvals 3X as fast at 1/3 the cost of new drugs.